• Skip to main content
  • Skip to secondary menu
  • Skip to footer
Mass Tort News

Mass Tort News

News Articles for Mass Tort Attorneys

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
  • Home
  • News
  • LegalCast
  • Live Trials
  • Meet the Team
  • Contact Us

LegalCast

Mass Tort News presents “LegalCast” hosted by Mark York and Elisa D’ Amico. Welcome to the front line of breaking news in mass torts and other complex litigation areas, where we provide real-time intel and opinion in dockets that are changing history. Mass Tort News and LegalCast offer access to MDL leadership as well guest host reporters from Bloomberg News who moderate our panel discussions and interviews. We offer industry leaders and insight into all aspects of a successful mass tort practice. We also offer unique access and guidance in other commercial practice areas including Qui Tam, Class Action, Human Trafficking, Products Liability and others that your firms engage in.

Subscribe to the LegalCast YouTube Channel

Mass Tort News LegalCast

Or listen on your favorite podcast app!

Recent Episodes

Mass Tort News LegalCast

Mass Tort News presents "LegalCast" hosted by Mark York and Elisa D'Amico. Welcome to the front line of breaking news in mass torts and other complex litigation areas, where we provide real-time intel and opinion in dockets that are changing history. Mass Tort News and LegalCast offer access to MDL leadership as well guest host reporters from Bloomberg News who moderate our panel discussions and interviews. We offer industry leaders and insight into all aspects of a successful mass tort practice. We also offer unique access and guidance in other commercial practice areas including Qui Tam, Class Action, Human Trafficking, Products Liability and others that your firms engage in.

Mass Tort News LegalCast
Keegan Hamilton currently serves as a Sr Reporter and Correspondent for VICE, focusing on organized crime, prisons, and the drug trade. Keegan also hosts two podcasts which also focus on the use and distribution of illicit drugs, Chapo: Kingpin on Trial and Painkiller: America's Fentanyl Crisis. Keegan has regularly written for other big-name news outlets including Medium, Business Insider, BuzzFeed, The Atlantic, Salon, and The Village Voice, to name a few. National Council on Crime and Delinquency honored Keegan’s reporting work with the 2011 P.A.S.S. Award, given to “those that help people understand the complex causes of crime and what must be done to prevent and control it.” Recently, Keegan investigated a Chinese fentanyl smuggler system that funnels drugs into the US through Mexico.

Keegan Social:
Instagram: https://www.instagram.com/hamiltonkeegan/?hl=en
Twitter: https://twitter.com/keegan_hamilton?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Eauthor
Muckrack: https://muckrack.com/keegan_hamilton
LinkedIn: https://www.linkedin.com/in/keegan-hamilton-697b5043/
Website: http://www.keeganhamilton.com/

Chapo: Kingpin on Trial - https://open.spotify.com/show/3iZGZfoQX9kfzdZtAYi2s2 

Painkiller: America's Fentanyl Crisis - https://open.spotify.com/show/2G3qmhWe8reqyCc7SRqI8F 

Remember to subscribe and follow us on social media…

LinkedIn: https://www.linkedin.com/company/mass-tort-news
Twitter: https://www.twitter.com/masstortnewsorg
Facebook: https://www.facebook.com/masstortnews.org
China, Big Pharma, and Fentanyl: Who’s Doing What to Stop Fentanyl Exports?
Check out the full episode here: https://youtu.be/OkWCf0xJW0c

Bijan Esfandiari serves as Senior shareholder at Baum Hedlund Aristei & Goldman, litigating cases of pharmaceutical product liability. Bijan discusses his current MDL (No. 3036) against pharmaceutical company Merck for the production and distribution of Gardasil, an HPV vaccine believed to cause POTS. Esfandiari explains how the defense shames victims of the toxic vaccine into silence by labeling them “anti-vaxers.” Esfandiari also actively worked on the 2010 GlaxoSmithKline (GSK) litigation, which resulted in $750 million settlement in civil and criminal claims over the company’s manufacturing of contaminated medication. Esfandiari received a unanimous agreement from a three-judge panel for his arguments in both McCormick v. Medtronic, Inc. and Mason v. SmithKline Beecham Corp.

With over 20 years of experience in law, Esfandiari holds great passion for helping others, specifically those harmed by large corporations. Bijan’s most recent honors include being named to the 2022 of Best Lawyers in America®, Lawdragon’s 2022 list of Leading Plaintiff Consumer Lawyers, and Law360’s 2021 series of Regional Powerhouses in California. Bijan also received recognition on the Southern California Super Lawyers® list of Rising Stars annually since 2009. Esfandiari remains active in the law community outside of the courtroom by speaking at national law conferences and serving as a member of the pro-bono Representative Assembly of the Palms Neighborhood Council. Bijan maintains membership in the American Association for Justice’s Leader’s Forum, the Consumer Attorneys Association of Los Angeles, and UCLA Journal of International Law & Foreign Affairs. Bijan speaks fluent Farsi and conversational German. 

Bijan Esfandiari LinkedIn: https://www.linkedin.com/in/bijanesfandiari/ 

Baum Hedlund Aristei & Goldman Social Media: 
LinkedIn: https://www.linkedin.com/company/baum-hedlund-aristei-&-goldman-pc/ 
Facebook: https://www.facebook.com/BaumHedlund 

Wingerter et al v. Merck & Co., Inc docket: https://dockets.justia.com/docket/multi-district/jpml/GAN/1:22-CV-01178/1521740 

McCormick v. Medtronic, Inc. docket: https://cite.case.law/md-app/219/485/

Mason v. SmithKline Beecham Corp.: https://caselaw.findlaw.com/us-7th-circuit/1508982.html 

GlaxoSmithKline (GSK) litigation: https://www.baumhedlundlaw.com/blog/2010/october/gsk-settles-whistleblower-lawsuit/ 

Palms Neighborhood Council: http://palmsnc.la/ 


Remember to subscribe and follow us on social media…

LinkedIn: https://www.linkedin.com/company/mass-tort-news
Twitter: https://www.twitter.com/masstortnewsorg
Facebook: https://www.facebook.com/masstortnews.org
Producer's Power Moments: Gardasil Vaccine MDL 3606 with Bijan Esfandiari, a Post JPML Hearing
Bijan Esfandiari serves as Senior shareholder at Baum Hedlund Aristei & Goldman, litigating cases of pharmaceutical product liability. Bijan discusses his current MDL (No. 3036) against pharmaceutical company Merck for the production and distribution of Gardasil, an HPV vaccine believed to cause POTS. Esfandiari explains how the defense shames victims of the toxic vaccine into silence by labeling them “anti-vaxers.” Esfandiari also actively worked on the 2010 GlaxoSmithKline (GSK) litigation, which resulted in $750 million settlement in civil and criminal claims over the company’s manufacturing of contaminated medication. Esfandiari received a unanimous agreement from a three-judge panel for his arguments in both McCormick v. Medtronic, Inc. and Mason v. SmithKline Beecham Corp.

With over 20 years of experience in law, Esfandiari holds great passion for helping others, specifically those harmed by large corporations. Bijan’s most recent honors include being named to the 2022 of Best Lawyers in America®, Lawdragon’s 2022 list of Leading Plaintiff Consumer Lawyers, and Law360’s 2021 series of Regional Powerhouses in California. Bijan also received recognition on the Southern California Super Lawyers® list of Rising Stars annually since 2009. Esfandiari remains active in the law community outside of the courtroom by speaking at national law conferences and serving as a member of the pro-bono Representative Assembly of the Palms Neighborhood Council. Bijan maintains membership in the American Association for Justice’s Leader’s Forum, the Consumer Attorneys Association of Los Angeles, and UCLA Journal of International Law & Foreign Affairs. Bijan speaks fluent Farsi and conversational German. 

Bijan Esfandiari LinkedIn: https://www.linkedin.com/in/bijanesfandiari/ 

Baum Hedlund Aristei & Goldman Social Media: 
LinkedIn: https://www.linkedin.com/company/baum-hedlund-aristei-&-goldman-pc/ 
Facebook: https://www.facebook.com/BaumHedlund 

Wingerter et al v. Merck & Co., Inc docket: https://dockets.justia.com/docket/multi-district/jpml/GAN/1:22-CV-01178/1521740 

McCormick v. Medtronic, Inc. docket: https://cite.case.law/md-app/219/485/

Mason v. SmithKline Beecham Corp.: https://caselaw.findlaw.com/us-7th-circuit/1508982.html 

GlaxoSmithKline (GSK) litigation: https://www.baumhedlundlaw.com/blog/2010/october/gsk-settles-whistleblower-lawsuit/ 

Palms Neighborhood Council: http://palmsnc.la/ 


Remember to subscribe and follow us on social media…

LinkedIn: https://www.linkedin.com/company/mass-tort-news
Twitter: https://www.twitter.com/masstortnewsorg
Facebook: https://www.facebook.com/masstortnews.org
Gardasil Vaccine MDL 3606 with Bijan Esfandiari, a Post JPML Hearing Update
Based in Massachusetts, Tucker Merrigan serves as co-founder and co-managing partner of Sweeney Merrigan Law, LLP. Tucker specializes in plaintiff personal injury law, specifically mass torts relating to defective medical devices and opioids. Tucker has received national recognition for his litigation work. From 2018-2021, Super Lawyers recognized him as a Rising Star. The National Trial Lawyers also named Tucker to their Top 40 Under 40 Trial Attorney list for six years running (2015-2021). He is a member of the American Association for Justice, the Massachusetts Academy of Trial Attorneys, the Boston Bar Association, and the Massachusetts Bar Association. Outside of running his law practice, Tucker enjoys volunteering as a “Big Brother” mentor at Boston’s Big-Brother Big-Sister Foundation.

Merrigan intro page: https://www.sweeneymerrigan.com/about-our-law-firm/attorneys/j-tucker-merrigan/ 

Tucker Personal Socials:
LinkedIn: https://www.linkedin.com/in/tuckermerrigan/

Sweeney Merrigan socials:
Facebook: https://www.facebook.com/sweeneymerrigan/?ref=br_rs
Twitter: https://twitter.com/sweeneymerrigan
LinkedIn: https://www.linkedin.com/company/sweeney-merrigan-law/

Remember to subscribe and follow us on social media…

LinkedIn: https://www.linkedin.com/company/mass-tort-news
Twitter: https://www.twitter.com/masstortnewsorg
Facebook: https://www.facebook.com/masstortnews.org
Success: It's Not Magical or Mystical with Tucker Merrigan
As a partner at DiCello Levitt, Robert “Bobby” DiCello holds decades of experience litigating cases of personal injury, product injury and civil rights abuses. DiCello received national fame for serving as an expert source for ABC News’ coverage of the death of George Floyd, the trial of Derek Chauvin, and the subsequent documentary on both. DiCello has received numerous litigious honors, including annual recognition on the Ohio Super Lawyers list for five years running. Public Justice honored Bobby with the title of Trial Lawyer of the Year for his work in Black v. Hicks in 2021. The National Law Journal has also recognized Bobby as an “agent of change” twice (2017 and 2020), a feat few lawyers achieve once. DiCello currently serves as Editor-in-Chief of The Cleveland State Law Review and has recently begun defending the publicized Jayland Walker, a Akron man killed by police. He holds memberships in National Police Accountability Project, Ohio Association for Justice, and the American Association for Justice.

https://dicellolevitt.com/attorney/bobby-dicello/ 

https://www.youtube.com/watch?v=08Vj0zlnBPw

Robert “Bobby” J. DiCello social media
Linkedin: https://www.linkedin.com/in/bobby-dicello-4826a5158/
twitter: https://twitter.com/BobbyDicello

DiCello Levitt Gutzler social media
LinkedIn: https://www.linkedin.com/company/dicellolevitt/
Facebook: https://www.facebook.com/DiCelloLevitt
Twitter: https://twitter.com/dicellolevitt

Remember to subscribe and follow us on social media…

LinkedIn: https://www.linkedin.com/company/mass-tort-news
Twitter: https://www.twitter.com/masstortnewsorg
Facebook: https://www.facebook.com/masstortnews.org
The Jayland Walker Akron Police Shooting “What’s the Answer, or is There One?”
Lamar Uquhart enlisted in the US Marine Corp in 1981 as a senior in high school and trained as an electrician at Camp Lejeune’s Courthouse Bay where he served until his 1982 deployment to Okinawa, Japan. Uquhart spent his next five years of active service shifting between Camp Lejeune, Cherry Point, NC, Okinawa, Japan, and San Diego. Spending his final year in the reserves, Uquhart received an honorable discharge in 1987 for his six full years of service. 

In 1983, the US military learned that Camp Lejeune's water contained high levels of toxic chemicals caused by an underground fuel leak. Although the Military knew thousands of marines and their families drank and bathed in contaminated water for decades, Urquhart only learned of his exposure after he began developing health conditions in 2009. By 2017, doctors officially diagnosed Lamar with H-Pylori, a bacterial infection of the stomach commonly contracted from exposure to contaminated water. To date, Uquhart suffers from 23 health conditions, most of which stem from exposure to polluted water. Though thousands of marines were poisoned from the US Military’s negligence, survivors of Lejeune struggle to receive healthcare and general support from the office of Veterans Affairs. Lamar advocates for himself and fellow survivors through social media activity and the advocacy group, Justice for Lejeune: https://justiceforlejeune.org/.

ATSDR report: https://www.atsdr.cdc.gov/sites/lejeune/tce_pce.html


Remember to subscribe and follow us on social media…

LinkedIn: https://www.linkedin.com/company/mass-tort-news
Twitter: https://www.twitter.com/masstortnewsorg
Facebook: https://www.facebook.com/masstortnews.org
From U.S. Marine to Toxic Exposed Veteran: Life After Camp Lejeune
Load More... Subscribe

Footer

Search

Main Navigation

  • Home
  • News
  • LegalCast
  • Live Trials
  • Meet the Team
  • Contact Us

Categories

Events

Trial Lawyers Summit 2022

February 16, 2022 By Mass Tort News

2021 Trial Lawyers Summit Recap

May 11, 2021 By Mark York

2021 TRIAL LAWYERS SUMMIT

May 4, 2021 By Mass Tort News

More Posts from this Category

MASS TORT NEWS

Latest Mass Tort Litigation News

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Copyright © 2022 · Mass Tort News · All Rights Reserved.